BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center

Pulsed Shortwave Neuromodulation Therapy (ActiPatch®) Study in Chronic Lower Back Pain. FREDERICK, MD, March 08, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL) https://www.bielcorp.com is pleased to announce the commencement of a clinical study investigating….


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.